So you're predicting revenue will not have grown from the March quarter then?
To be fair, the company has received an R&D refund for several years and it is a welcome recoupment of a portion of the staff & admin costs that are incurred throughout the year to develop the various products that are now being sold to and deployed in various B2B ecosystems. I also do not recall AF ever having used the receipt of an R&D refund as demonstrative of revenue growth, but more than happy for you to pull up the relevant quotes (as I said, I don't recall it).
Bottom is in. Get ready for SPENDA to bounce!, page-850
-
- There are more pages in this discussion • 470 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
-0.001(10.0%) |
Mkt cap ! $38.92M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.1¢ | 0.9¢ | $6.453K | 655.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 6012211 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 1273575 | 5 |
View Market Depth
| Last trade - 14.17pm 02/08/2024 (20 minute delay) ? |
| SPX (ASX) Chart |